Search

everythinglearnresearchcommunity

for

Search:↓

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Isolated long hairs at the original hairline can help diagnose Frontal Fibrosing Alopecia.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Alopecia areata and non-alcoholic fatty liver disease might be linked, but more research is needed.

FGF signaling is crucial for starting feather development in chicken embryos.

Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.

Frontal fibrosing alopecia and vitiligo might be linked, not just coincidental.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

BAF200 is essential for proper heart and coronary artery formation.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Fractional microneedle radiofrequency is a safe and effective skin treatment with minimal serious side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Referral rates for anaphylaxis patients improved significantly after implementing guidelines.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Finasteride increases risk of sleep apnea and insomnia.